Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

CME Group

CME

NEUTRAL

May 22, 2026

Research Conclusion

CME Group is the dominant US derivatives exchange operator with monopoly-like positioning in IR futures, equity index, energy, and FX/metals. At 24.3x FY2026E adj EPS + ~4% dividend yield (regular + variable), the stock is fairly valued. PWFV ~$308-315 (+10-13%); plus ~4% dividend = ~14-17% three-year total return. Quality compounder; limited upside at current valuation; better entries available.

Company Overview & Moat Assessment

CME Group is the world's largest derivatives exchange and clearinghouse, operating Chicago Mercantile Exchange + Chicago Board of Trade + NYMEX + COMEX. FY2025 revenue $6.4B; adj EPS $11.16; 29M ADV of contracts. Four product groups: Interest Rates (~38%), Equity Index (~22%), Energy/Commodities (~25%), FX/Metals (~15%). Plus CME Securities Clearing + market data. Operating margin ~63%; FCF margin ~64%. Pays regular dividend (~$4.96/yr) and annual variable dividend ($5-6.50). Monopoly economics with structural IR volume tailwind from $36T+ US federal debt.

▲ Bull Case

  • IR ADV floor structurally 22-24M+ in normalized environment: US federal debt $36T+ vs. $14T in 2010 = more duration hedging structurally; SOFR embedding in trillions of commercial loans = persistent IR derivative demand
  • CME Securities Clearing captures 15-20% of $26T Treasury market: Treasury clearing mandate (Dec 2026) creates new TAM; CME-FICC cross-margining structural advantage; $100-200M+ incremental annual revenue at ~80% margin
  • Variable dividend remains $6+ + EPS growth = sustained 14-17% total return: Mechanical dividend + EPS compounding = quality compounder return profile

▼ Bear Case

  • Rate cycle ends; IR ADV reverts to 2010-2015 levels (~15-17M): Volume -25%; revenue -$1.5B; EPS to $8-9
  • FMX captures 10-15% of Treasury futures share: Competitive moat erosion; pricing power decline
  • Multiple compresses to 20x as growth narrative fades: $230 = -18%
Primary Debate on Wall Street

Whether elevated IR volumes are cyclical (Fed activity) or structural (debt + SOFR). Treasury clearing optionality is partially priced.

Top Catalysts
  • Q2 2026 ADV by Jul 2026: >30M = bull signal
  • Treasury clearing adoption by Q3-Q4 2026: >$50B/day volume
  • FY2026 variable dividend by Feb 2027: $6.50+/share
  • Treasury clearing mandate goes live Dec 31, 2026: Market share capture
  • FMX market share quarterly tracking: <5% confirms moat durability
Top Risks
  • Rate normalization causing IR ADV reversion to 2010-2015 levels (~15-17M), reducing revenue -$1.5B and EPS to $8-9
  • FMX capturing 10-15% of Treasury futures share, eroding competitive moat and pricing power
  • Multiple compression to 20x as growth narrative fades, driving stock to $230 (-18%)

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/CME/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.